Clinical Trials Update: April 19, 2006

Psoriasis Genital Herpes Skin Cancer

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Psoriasis

This is a 5-year research study to evaluate an investigational drug for moderate-to-severe psoriasis. Candidates must be at least 18 years old. Participants receive a study-related investigational drug, physical and skin exams, and lab work. Compensation is provided for time and travel expenses.

The research site is in Mount Pleasant, S.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat126.html.

-----

Genital Herpes

Novartis Pharmaceuticals is evaluating whether a one-day treatment with the drug famciclovir is safe and effective in people with recurrent genital herpes. Volunteers 18 and older who have had at least four genital herpes outbreaks in the prior 12 months and who are willing to discontinue current medication to suppress herpes outbreaks may qualify.

The research sites are located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat173.html.

-----

Skin Cancer

This is a clinical study for people with surgically incurable metastatic melanoma who have received no prior chemotherapy, immunotherapy or biological therapy for the treatment of metastatic disease. Patients who have surgically incurable melanoma, serum lactic acid dehydrogenase (LDH) <= 2 x ULN, and ECOG performance status of 0 or 1 may qualify.

The research sites are located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat37.html.

-----

Copyright 2006 CenterWatch. All rights reserved.

Consumer News